Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product -
ALXN: To Present At UBS Global Life Sciences Conference @ 16:30 ET [delayed] -
Alexion Pharmaceuticals Picks Up Volume, Challenges Support -
CORRECTION - Alexion Pharmaceuticals Challenges Support -
Alexion Pharmaceuticals Challenges Support -
Alexion Pharmaceuticals Inc reports receipt of US patent for ALXN6000 -
ALXN: To Present At IBC Life Sciences DDT 2008 Conference @ 11:05 ET [delayed] -
Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody -
Alexion Biotech One-Drug Reliant -
Cheshire, Conn.-based Alexion Pharmaceuticals posts first profit -
Alexion Pharmaceuticals Breaks Resistance, Hits New High -
Alexion, CuraGen report positive earnings for 2Q -
ALXN hits 52-week high at 91.08 -
Alexion Pharmaceuticals Closes At New High On Surprise Quarterly Profit -
Alexion Pharmaceuticals Rises On Q2 Profit, Stock Split -
ALXN: Q2 Earnings Call @ 10:00 ET Today [delayed] -
Alexion Reports Second Quarter 2008 Results -
Alexion Pharmaceuticals Closed at New 52-Week High Friday -
Alexion Pharmaceuticals (ALXN) NewsBite - ALXN Jumps on Buy Rating -